HIGHLIGHT CAPITAL
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
HIGHLIGHT CAPITAL
Industry:
Finance Health Care
Founded:
2014-01-01
Status:
Active
Contact:
+862162790758
Technology used in webpage:
SPF Domain Not Resolving IIS IIS 7 Alibaba HiChina DNS Alibaba Cloud MailBox
Similar Organizations
Gilde Healthcare
Gilde Healthcare is a healthcare investor that does lower mid-market buyouts and later stage venture.
Current Advisors List
Dhruv Sharma External Advisor @ Highlight Capital Advisor
Current Employees Featured
Alvin Yan
Alvin Yan Vice President @ Highlight Capital Vice President
Jenny Jiang
Jenny Jiang Executive Director @ Highlight Capital Executive Director
Steven Wang
Steven Wang Managing & Founding Partner @ Highlight Capital Managing & Founding Partner
Tongle Yu
Tongle Yu Partner @ Highlight Capital Partner
Jason Zhao
Jason Zhao Founding Partner @ Highlight Capital Founding Partner
Bing Chen
Bing Chen Vice President @ Highlight Capital Vice President
Founder
Jason Zhao
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-03-29 | Yaotan Pharmaceutical | Highlight Capital investment in Series A - Yaotan Pharmaceutical | 200 M CNY |
2022-03-14 | Medilink Therapeutics | Highlight Capital investment in Series B - Medilink Therapeutics | 70 M USD |
2022-01-04 | Bichen Pharmaceutical | Highlight Capital investment in Series B - Bichen Pharmaceutical | 30 M USD |
2021-12-31 | SparX Group | Highlight Capital investment in Series B - SparX Group | 30 M USD |
2021-12-28 | Thousand Oaks Biopharmaceuticals | Highlight Capital investment in Venture Round - Thousand Oaks Biopharmaceuticals | 1.5 B CNY |
2021-12-20 | ColorTech Bio | Highlight Capital investment in Series B - ColorTech Bio | 150 M CNY |
2021-11-22 | Qinghui Liannuo | Highlight Capital investment in Seed Round - Qinghui Liannuo | 100 M CNY |
2021-09-29 | Vision X | Highlight Capital investment in Series B - Vision X | N/A |
2021-06-01 | Inmagene Biopharmaceuticals | Highlight Capital investment in Series C - Inmagene Biopharmaceuticals | 100 M USD |
2021-05-25 | Chongxing Chongwu | Highlight Capital investment in Series B - Chongxing Chongwu | 400 M CNY |